Literature DB >> 23108503

Cost control in a parallel universe: Medicare spending in the United States and Canada.

David U Himmelstein, Steffie Woolhandler.   

Abstract

Mesh:

Year:  2012        PMID: 23108503     DOI: 10.1001/2013.jamainternmed.272

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  6 in total

1.  Life or debt: underinsurance in America.

Authors:  Steffie Woolhandler; David U Himmelstein
Journal:  J Gen Intern Med       Date:  2013-09       Impact factor: 5.128

2.  Cancer drugs in the United States: Justum Pretium--the just price.

Authors:  Hagop M Kantarjian; Tito Fojo; Michael Mathisen; Leonard A Zwelling
Journal:  J Clin Oncol       Date:  2013-05-06       Impact factor: 44.544

3.  The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

Authors: 
Journal:  Blood       Date:  2013-04-25       Impact factor: 22.113

4.  Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.

Authors:  Jennifer E Vaughn; Megan Othus; Morgan A Powell; Kelda M Gardner; Donelle L Rizzuto; Paul C Hendrie; Pamela S Becker; Paul S Pottinger; Elihu H Estey; Roland B Walter
Journal:  JAMA Oncol       Date:  2015-11       Impact factor: 31.777

5.  Preoperative consultations for medicare patients undergoing cataract surgery.

Authors:  Stephan R Thilen; Miriam M Treggiari; Jane M Lange; Elliott Lowy; Edward M Weaver; Duminda N Wijeysundera
Journal:  JAMA Intern Med       Date:  2014-03       Impact factor: 21.873

6.  Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade.

Authors:  Junjie Xu; Minyue Tang; Jun Shen
Journal:  Gastroenterol Res Pract       Date:  2013-11-07       Impact factor: 2.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.